Loading...

Cannara Biotech Inc.

LOVFF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.32
$-0.03(-2.22%)

Cannara Biotech Inc. (LOVFF) Stock Overview

Explore Cannara Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap120.7M
P/E Ratio11.01
EPS (TTM)$0.12
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Week$0.85
1 Month$0.82
3 Months$0.82
1 Year Target$0.46

LOVFF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cannara Biotech Inc. (LOVFF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.01 and a market capitalization of 120.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.84%
5-Day Change
-3.71%
1-Month Change
-5.91%
3-Month Change
46.41%
6-Month Change
94.86%
Year-to-Date (YTD) Change
56.50%
1-Year Change
24.10%
3-Year Change
-6.03%
5-Year Change
40.80%
All-Time (Max) Change
-52.80%

Contact Information

https://cannara.ca
514-543-4200
333 Decarie Blvd., Saint-Laurent, QC, H4N 3M9

Company Facts

461 Employees
IPO DateJan 18, 2019
CountryCA
Actively Trading

Frequently Asked Questions

;